Media Releases

2021

23/04/2021

Proteomics International achieves ISO 13485 certification

08/02/2021

Proteomics International seeks FDA approval for PromarkerD

2020

12/11/2020

Middle East is next market for PromarkerD immunoassay test

05/11/2020

PromarkerD clinical assay performance results published

23/10/2020

Proteomics International raises $6m in heavily oversubscribed Placement

16/10/2020

First distribution agreement for PromarkerD immunoassay

12/10/2020

PromarkerD international validation study results published

09/10/2020

Partnership with QIMR Berghofer targets oesophageal cancer

27/07/2020

PromarkerD Intellectual Property portfolio expands

15/06/2020

Big pharma clinical study validates PromarkerD kidney test

25/05/2020

Proteomics International receives COVID-19 research grants

16/04/2020

CE Mark for PromarkerD Immunoassay Kit

07/04/2020

Diagnostics R&D expanded: the Promarker™ Pipeline

31/03/2020

Proteomics International expands study with US big pharma

23/03/2020

Proteomics International to patent biomarkers for diagnosis of endometriosis

1
2
3
4
5
6
7
8
9